Human papillomavirus (HPV) and HPV vaccine awareness in Indigenous communities in Northwest Territories, Canada.
This community-based mixed-methods survey of 221 Indigenous adults across 11 Northwest Territories communities found low HPV and HPV-vaccine awareness, low reported vaccination among participants aged up to 26 years, and awareness differences associated with education, age, and gender.
Open original publication →What the AI sees
This community-based mixed-methods survey of 221 Indigenous adults across 11 Northwest Territories communities found low HPV and HPV-vaccine awareness, low reported vaccination among participants aged up to 26 years, and awareness differences associated with education, age, and gender.
Research significance
The study provides observational evidence that limited awareness and insufficient information are barriers to HPV vaccination; it is reasonable—but not tested here—to hypothesize that culturally tailored school- and community-based education linking HPV to cancer could increase vaccine uptake and thereby strengthen long-term cancer prevention.
Source abstract
OBJECTIVES: Human papillomavirus (HPV) is a common sexually transmitted infection linked to several cancers, including cervical cancer, which ranks fourth in cancer incidence and mortality among women globally. Despite its significance, awareness of HPV and the HPV vaccine remains limited across many populations. This project assessed HPV and HPV vaccine awareness among Indigenous adults in Northwest Territories communities in Canada and explored factors influencing HPV vaccine utilization; such data have never been available or explored. METHODS: Using a community-based participatory research approach, quantitative and qualitative data were collected in 11 Indigenous communities in Northwest Territories. Indigenous adults aged 18 years and older were invited to complete a semi-structured questionnaire administered by trained local research assistants. Multiple logistic regression was used to examine potential associations among age, gender, education, and awareness of HPV and the HPV vaccine. A thematic analysis of qualitative data explored reasons for non-vaccination. RESULTS: Among the 221 participants (66.5% women; mean age 43.6 years (±13.9)), approximately half had heard of HPV, and fewer than one-third had heard of the HPV vaccine. Education emerged as a key factor, with individuals with lower educational attainment being significantly less aware of HPV (p < .000). Age (p < .033), gender (p < .019), and education (p < .004) predicted vaccine awareness, with women, individuals with higher education, and younger adults being more likely to have heard about the vaccine. Only 26.3% of participants aged up to 26 years had received the HPV vaccine. Qualitative data revealed that limited awareness and insufficient information about HPV and the vaccine are the main barriers to vaccination. Participants recommended enhancing vaccine promotion by raising awareness about the connection between HPV and cancer, as well as increasing educational efforts in schools and communities. CONCLUSIONS: Limited awareness of the HPV vaccine may contribute to low vaccination rates. Tailored and targeted interventions are crucial to increasing HPV vaccine utilization in Indigenous communities in Northwest Territories.